Industry Focus Transcripts

Shopify and its founder, Tobias Lutke, have been Fool favorites for a long time. On this episode we talk about why, despite the stock's crazy run over the past year, we'd still buy shares of this e-commerce company.

Today, we dust off our college accounting books to talk about the difference between capitalizing and expensing a purchase, what deferred revenue is, and why operating leverage is a beautiful thing.

Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic's already investing billions in Mazor Robotics, a maker of surgical robots.

Amazon has already begun to weaponize its Whole Foods locations -- we look at how competing retailers are feeling the pressure.

Two years ago we tossed out a terrible ballpark on the revenue Apple Music might be able to bring in for the tech giant. Today we talk about that mistake and how to set yourself up to make better projections.

There are a lot of good bankers, but these seven are certainly among the best.

Don't get sick before you see this informative quick guide.

The retail giant won't be using a one-size-fits-all model as it grows its new format.

Auto sales have declined 2% this year after sales broke records in 2016, leading to speculation about whether the U.S. has reached peak auto. However, one area of the market -- SUVs, light trucks, and crossovers -- continues to demonstrate growth.

Alarm.com, Impinj, and Paycom aren't household names yet, but they are transforming markets worth billions of dollars, and that could make them savvy investments.

The FDA approved the world's first CAR-T therapy on Wednesday, one month ahead of schedule, and only days after Gilead Sciences announced it’s buying CAR-T powerhouse Kite Pharma in a deal valued at $11.9 billion.

Join us for a look at the incredible growth of e-sports and the opportunity it presents to various industry stakeholders, including game publishers, content networks, and the players themselves.

How investors should look at the increasing trend toward green energy and away from coal and gas.

The Industry Focus team looks at the growing popularity of online education.

We rip open the mailbag and answer questions regarding clinical trials, drug patents, and retail pharmacy profits.

After years of being dubbed “death traps” for investors, the airlines industry is having something of a renaissance. We discuss which of the big four U.S. national carriers is the better buy for investors today.

It’s not always an easy decision, and in most cases you should do some planning first, but there are times when you’re doing the right thing by quitting your job.

Two Fools explain share buybacks, dividends, and other ways of returning capital to shareholders.

"Industry Focus: Financials" looks at statistics about emergency savings, credit cards, retirement saving, stock investing, and homeownership.

Marijuana use is growing quickly, but that isn’t the only reason Constellation Brands is taking an equity stake in Canopy Growth.